Amicus Therapeutics Inc. (Nasdaq: FOLD) will delay the approval filing for its Fabry disease treatment Amigal sending the stock price plummeting 65 cents to close at $2.54.
Amicus Delays Filing
June 17, 2013 at 17:40 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
| ||||||